Therapeutic Classification: antiplatelet agents
Pharmacologic Classification: anti-von Willebrand Factor, monoclonal antibodies
REMS
Absorption: IV administration results in complete bioavailability; 90% absorbed following SUBQ administration.
Distribution: Minimally distributed to tissues.
Half-Life: Unknown.
Contraindicated in:
Use Cautiously in:
Drug-drug: